Morningstar5 天
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T ...
YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for ...
Taiwan News4 天
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T ...
YONGIN, South Korea, March 13, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 ...